Acuitas Therapeutics

Acuitas Therapeutics is a biotech company specializing in developing delivery systems for messenger RNA (mRNA) vaccines and therapies. They create lipid nanoparticles—tiny fat-based capsules—that protect mRNA molecules and help them enter human cells effectively. This technology is essential for the success of mRNA-based vaccines like those for COVID-19, allowing these medicines to work safely and efficiently. Acuitas’s innovations have become foundational in modern vaccine development, contributing to rapid responses to health crises and advancing personalized medicine approaches.